Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease-Reference-Cited by-同舟云学术

Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease

Published:2020-07-09 Issue:13 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Zhao Yan,Qin Ling,Zhang Ping^ORCID,Li Kang,Liang Lianchun,Sun Jianping,Xu Bin,Dai Yanchao,Li Xuemei,Zhang Chi,Peng Yanchun,Feng Yingmei^ORCID,Li Ang,Hu Zhongjie,Xiang Haiping,Ogg Graham,Ho Ling-Pei,McMichael Andrew,Jin Ronghua,Knight Julian C.^ORCID,Dong Tao,Zhang Yonghong

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/139834/files/pdf

Reference27 articles.

1. [No authors listed]. Coronavirus disease (COVID-19) pandemic. World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Accessed June 11, 2020

2. A new coronavirus associated with human respiratory disease in China

3. A Novel Coronavirus from Patients with Pneumonia in China, 2019

4. Coronaviruses: An Overview of Their Replication and Pathogenesis

5. Coronaviruses post-SARS: update on replication and pathogenesis

Cited by 329 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, triple-blinded, placebo-controlled clinical trial evaluating immune responses of Typhim Vi and PPSV23 vaccines in healthy adults: The PREP study;Vaccine;2024-12

2. IL-10 induces activated phenotypes of monocytes observed in virally-suppressed HIV-1-infected individuals;Biochemical and Biophysical Research Communications;2024-10

3. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing;Frontiers in Pharmacology;2024-09-13

4. A spatially resolved single-cell lung atlas integrated with clinical and blood signatures distinguishes COVID-19 disease trajectories;Science Translational Medicine;2024-09-11

5. Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses;Human Vaccines & Immunotherapeutics;2024-09-09